0001104659-16-163806.txt : 20161223 0001104659-16-163806.hdr.sgml : 20161223 20161223180340 ACCESSION NUMBER: 0001104659-16-163806 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161024 FILED AS OF DATE: 20161223 DATE AS OF CHANGE: 20161223 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CRISPR Therapeutics AG CENTRAL INDEX KEY: 0001674416 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 473173478 STATE OF INCORPORATION: V8 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 BUSINESS PHONE: 6173154600 MAIL ADDRESS: STREET 1: AESCHENVORSTADT 36 CITY: BASEL STATE: V8 ZIP: 4051 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital V (Canada), LP CENTRAL INDEX KEY: 0001612235 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 162069512 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Ophthalmic Affiliates I, L.P. CENTRAL INDEX KEY: 0001589098 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 162069513 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital V, L.P. CENTRAL INDEX KEY: 0001589097 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 162069515 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Side Fund IV, L.P. CENTRAL INDEX KEY: 0001456591 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 162069516 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-2211 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Venture Capital IV, L.P. CENTRAL INDEX KEY: 0001456590 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 162069517 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-2211 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Versant Affiliates Fund V, L.P. CENTRAL INDEX KEY: 0001589095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37923 FILM NUMBER: 162069514 BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 650-233-7877 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: SUITE 3630 CITY: SAN FRANCISCO STATE: CA ZIP: 94104 4/A 1 a4a.xml 4/A X0306 4/A 2016-10-24 2016-10-26 0 0001674416 CRISPR Therapeutics AG CRSP 0001456590 Versant Venture Capital IV, L.P. ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001456591 Versant Side Fund IV, L.P. ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001589097 Versant Venture Capital V, L.P. ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001589095 Versant Affiliates Fund V, L.P. ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001589098 Versant Ophthalmic Affiliates I, L.P. ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 0001612235 Versant Venture Capital V (Canada), LP ONE SANSOME STREET, SUITE 3630 SAN FRANCISCO CA 94104 0 0 1 0 Common Stock 2016-10-24 4 C 0 437247 A 676895 I Footnote Common Stock 2016-10-24 4 C 0 3100477 A 3777372 I Footnote Common Stock 2016-10-24 4 C 0 231077 A 4008449 I Footnote Common Stock 2016-10-24 4 P 0 95596 14.00 A 4104045 I Footnote Common Stock 2016-10-24 4 C 0 2754 A 2754 I Footnote Common Stock 2016-10-24 4 C 0 19524 A 22278 I Footnote Common Stock 2016-10-24 4 C 0 1454 A 23732 I Footnote Common Stock 2016-10-24 4 P 0 602 14.00 A 24334 I Footnote Common Stock 2016-10-24 4 C 0 2210417 A 2210417 I Footnote Common Stock 2016-10-24 4 C 0 173167 A 2383584 I Footnote Common Stock 2016-10-24 4 P 0 60219 14.00 A 2443803 I Footnote Common Stock 2016-10-24 4 C 0 66490 A 66490 I Footnote Common Stock 2016-10-24 4 C 0 5210 A 71700 I Footnote Common Stock 2016-10-24 4 C 0 168224 A 168224 I Footnote Common Stock 2016-10-24 4 C 0 13180 A 181404 I Footnote Common Stock 2016-10-24 4 P 0 4583 14.00 A 185987 I Footnote Common Stock 2016-10-24 4 C 0 73704 A 73704 I Footnote Common Stock 2016-10-24 4 C 0 5774 A 79478 I Footnote Series A-1 Preferred Shares 2016-10-24 4 C 0 437247 D Common Stock 437247 0 I See footnote Series A-1 Preferred Shares 2016-10-24 4 C 0 2754 D Common Stock 2754 0 I See footnote Series A-2 Preferred Shares 2016-10-24 4 C 0 3100477 D Common Stock 3100477 0 I See footnote Series A-2 Preferred Shares 2016-10-24 4 C 0 19524 D Common Stock 19524 0 I See footnote Series A-3 Preferred Shares 2016-10-24 4 C 0 2210417 D Common Stock 2210417 0 I See footnote Series A-3 Preferred Shares 2016-10-24 4 C 0 66490 D Common Stock 66490 0 I See footnote Series A-3 Preferred Shares 2016-10-24 4 C 0 168224 D Common Stock 168224 0 I See footnote Series A-3 Preferred Shares 2016-10-24 4 C 0 73704 D Common Stock 73704 0 I See footnote Series B Preferred Shares 2016-10-24 4 C 0 231077 D Common Stock 231077 0 I See footnote Series B Preferred Shares 2016-10-24 4 C 0 1454 D Common Stock 1454 0 I See footnote Series B Preferred Shares 2016-10-24 4 C 0 173167 D Common Stock 173167 0 I See footnote Series B Preferred Shares 2016-10-24 4 C 0 5210 D Common Stock 5210 0 I See footnote Series B Preferred Shares 2016-10-24 4 C 0 13180 D Common Stock 13180 0 I See footnote Series B Preferred Shares 2016-10-24 4 C 0 5774 D Common Stock 5774 0 I See footnote Each share of the Issuer's Series A-1 Preferred Stock, Series A-2 Preferred Stock, Series A-3 Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's Common Stock in its firm commitment initial public offering pursuant to the Issuer's prospectus (Form 424B4) filed with the Securities and Exchange Commission on October 19, 2016. These securities are held of record by Versant Venture Capital IV, L.P. ("VVC IV"). Versant Ventures IV, LLC ("VV IV") is the sole general partner of VVC IV and may be deemed to have voting and investment power over the securities held by VVC IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VVC IV, except to the extent of its pecuniary interests therein. These securities are held of record by Versant Side Fund IV, L.P. ("VSF IV"). VV IV is the sole general partner of VSF IV and may be deemed to have voting and investment power over the securities held by VSF IV and as a result may be deemed to have beneficial ownership over such securities, however, VV IV disclaims beneficial ownership of the securities held by VSF IV, except to the extent of its pecuniary interests therein. These securities are held of record by Versant Venture Capital V, L.P. ("VVC V"). Versant Ventures V, LLC ("VV V") is the sole general partner of VVC V and may be deemed to have voting and investment power over the securities held by VVC V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VVC V, except to the extent of its pecuniary interests therein. These securities are held of record by Versant Affiliates Fund V, L.P. ("VAF V"). VV V is the sole general partner of VAF V and may be deemed to have voting and investment power over the securities held by VAF V and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VAF V, except to the extent of its pecuniary interests therein. These securities are held of record by Versant Venture Capital V (Canada) LP ("VVC CAN"). Versant Ventures V (Canada) GP-GP, Inc. ("VV V CAN GP") is the sole general partner of Versant Ventures V (Canada), L.P. ("VV V CAN") and VV V CAN is the sole general partner of VVC CAN. VV V CAN GP and VV V CAN may be deemed to have voting and investment power over the securities held by VVC CAN and as a result may be deemed to have beneficial ownership over such securities, however, each disclaim beneficial ownership of the securities held by VVC CAN, except to the extent of their pecuniary interests therein. These securities are held of record by Versant Ophthalmic Affiliates Fund I, L.P. ("VOA"). VV V is the sole general partner of VOA and may be deemed to have voting and investment power over the securities held by VOA and as a result may be deemed to have beneficial ownership over such securities, however, VV V disclaims beneficial ownership of the securities held by VOA, except to the extent of its pecuniary interests therein. This amendment is being filed solely to report the conversion of preferred stock into common stock that occurred upon the closing of the Issuer's initial public offering (the "IPO") on October 24, 2016, which conversion was inadvertently omitted from the original Form 4 filed on October 26, 2016, and to correct the transaction code for the purchases in the IPO, which was previously reported as "A," and not to report any other transactions in securities of the Issuer. Versant Venture Capital IV, L.P. By: Versant Ventures IV, LLC By: Name: Robin L. Praeger Title: Managing Director 2016-12-23 Versant Side Fund IV, L.P. By: Versant Ventures IV, LLC By: Name: Robin L. Praeger Title: Managing Director 2016-12-23 Versant Venture Capital V, L.P. By: Versant Ventures V, LLC By: Name: Robin L. Praeger Title: Managing Director 2016-12-23 Versant Affiliates Fund V, L.P. By: Versant Ventures V, LLC By: Name: Robin L. Praeger Title: Managing Director 2016-12-23 Versant Ophthalmic Affiliates Fund I, L.P. By: Versant Ventures V, LLC By: Name: Robin L. Praeger Title: Managing Director 2016-12-23 Versant Venture Capital V (Canada) LP By: Versant Ventures V (Canada), L.P. By: Versant Ventures V GP-GP, Inc. By: Name: Robin L. Praeger Title: Director 2016-12-23